Patents by Inventor Sabrina DELONG

Sabrina DELONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF
    Publication number: 20220259310
    Abstract: The invention provides agonistic anti-human VISTA antibodies and antibody fragments. These agonist antibodies and antibody fragments may be used to potentiate or enhance or mimic VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity. These agonist antibodies and antibody fragments are especially useful in the treatment of autoimmunity, allergy, inflammatory conditions, GVHD, sepsis and transplant recipients. Screening assays for identifying these agonists are also provided.
    Type: Application
    Filed: March 1, 2022
    Publication date: August 18, 2022
    Inventors: Michael MOLLOY, Jay ROTHSTEIN, Catherine CARRIERE, Randolph J. NOELLE, Sabrina DELONG, Isabelle LEMERCIER
  • ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF
    Publication number: 20210317207
    Abstract: The invention provides agonistic anti-human VISTA antibodies and antibody fragments. These agonist antibodies and antibody fragments may be used to potentiate or enhance or mimic VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity. These agonist antibodies and antibody fragments are especially useful in the treatment of autoimmunity, allergy, inflammatory conditions, GVHD, sepsis and transplant recipients. Screening assays for identifying these agonists are also provided.
    Type: Application
    Filed: March 19, 2021
    Publication date: October 14, 2021
    Inventors: Randolph J. NOELLE, Sabrina DELONG, Michael MOLLOY, Catherine CARRIERE, Jay ROTHSTEIN, Isabelle LEMERCIER
  • ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF
    Publication number: 20210017281
    Abstract: The invention provides agonistic anti-human VISTA antibodies and antibody fragments. These agonist antibodies and antibody fragments may be used to potentiate or enhance or mimic VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity. These agonist antibodies and antibody fragments are especially useful in the treatment of autoimmunity, allergy, inflammatory conditions, GVHD, sepsis and transplant recipients. Screening assays for identifying these agonists are also provided.
    Type: Application
    Filed: April 14, 2017
    Publication date: January 21, 2021
    Inventors: Michael MOLLOY, Jay ROTHSTEIN, Catherine CARRIERE, Randolph J. NOELLE, Sabrina DELONG, Isabelle LEMERCIER
  • ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF
    Publication number: 20170306020
    Abstract: The invention provides agonistic anti-human VISTA antibodies and antibody fragments. These agonist antibodies and antibody fragments may be used to potentiate or enhance or mimic VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity. These agonist antibodies and antibody fragments are especially useful in the treatment of autoimmunity, allergy, inflammatory conditions, GVHD, sepsis and transplant recipients. Screening assays for identifying these agonists are also provided.
    Type: Application
    Filed: April 17, 2017
    Publication date: October 26, 2017
    Inventors: Randolph J. NOELLE, Sabrina DELONG, Michael MOLLOY, Catherine CARRIERE, Jay ROTHSTEIN, Isabelle LEMERCIER
  • ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF
    Publication number: 20170306024
    Abstract: The invention provides agonistic anti-human VISTA antibodies and antibody fragments. These agonist antibodies and antibody fragments may be used to potentiate or enhance or mimic VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity. These agonist antibodies and antibody fragments are especially useful in the treatment of autoimmunity, allergy, inflammatory conditions, GVHD, sepsis and transplant recipients. Screening assays for identifying these agonists are also provided.
    Type: Application
    Filed: April 17, 2017
    Publication date: October 26, 2017
    Inventors: Randolph J. NOELLE, Sabrina DELONG, Jay ROTHSTEIN, Isabelle LEMERCIER